These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1132 related articles for article (PubMed ID: 8056445)
1. Polyclonal uses of T-cell receptor (TCR)alpha and beta genes for cytotoxic T lymphocytes in human metastatic melanoma: possible involvement of TCR alpha in tumor-cell recognition. Seito D; Morita T; Masuoka K; Maeda T; Saya H; Itoh K Int J Cancer; 1994 Aug; 58(4):497-502. PubMed ID: 8056445 [TBL] [Abstract][Full Text] [Related]
2. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone. Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931 [TBL] [Abstract][Full Text] [Related]
3. Large and dissimilar repertoire of Melan-A/MART-1-specific CTL in metastatic lesions and blood of a melanoma patient. Mandruzzato S; Rossi E; Bernardi F; Tosello V; Macino B; Basso G; Chiarion-Sileni V; Rossi CR; Montesco C; Zanovello P J Immunol; 2002 Oct; 169(7):4017-24. PubMed ID: 12244204 [TBL] [Abstract][Full Text] [Related]
4. Two autologous melanoma-specific and MHC-restricted human T cell clones with identical intra-tumour reactivity do not share the same TCR V alpha and V beta gene families. Sensi M; Castelli C; Anichini A; Grossberger D; Mazzocchi A; Mortarini R; Parmiani G Melanoma Res; 1991; 1(4):261-71. PubMed ID: 1668534 [TBL] [Abstract][Full Text] [Related]
5. Expansion of major histocompatibility complex-restricted antimelanoma cytotoxic T-cell lymphocyte clones with identical T-cell receptor from tumor-infiltrating lymphocytes. Sensi M; Castelli C; Salvi S; Mazzocchi A; Mortarini R; Nicolini G; Anichini A; Parmiani G J Immunother (1991); 1992 Oct; 12(3):207-11. PubMed ID: 1332745 [TBL] [Abstract][Full Text] [Related]
6. Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope. Cole DJ; Weil DP; Shamamian P; Rivoltini L; Kawakami Y; Topalian S; Jennings C; Eliyahu S; Rosenberg SA; Nishimura MI Cancer Res; 1994 Oct; 54(20):5265-8. PubMed ID: 7522957 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1. Sensi M; Traversari C; Radrizzani M; Salvi S; Maccalli C; Mortarini R; Rivoltini L; Farina C; Nicolini G; Wölfel T Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5674-8. PubMed ID: 7777568 [TBL] [Abstract][Full Text] [Related]
9. TCR rearrangement in lymphocytes infiltrating melanoma metastases after administration of autologous dinitrophenyl-modified vaccine. Manne J; Mastrangelo MJ; Sato T; Berd D J Immunol; 2002 Sep; 169(6):3407-12. PubMed ID: 12218163 [TBL] [Abstract][Full Text] [Related]
10. The T cell receptor gene usage by simian immunodeficiency virus gag-specific cytotoxic T lymphocytes in rhesus monkeys. Chen ZW; Shen L; Regan JD; Kou Z; Ghim SH; Letvin NL J Immunol; 1996 Feb; 156(4):1469-75. PubMed ID: 8568249 [TBL] [Abstract][Full Text] [Related]
11. Dual recognition of a human cytotoxic T-cell clone for melanoma antigens. Kubo H; Abe J; Obata F; Nakajima H; Tsunoda M; Ogawa A; Nakayama S; Beck Y; Kohsaka T; Darrow TL; Abdel-Wahab Z; Saida T; Takiguchi M Cancer Res; 1996 May; 56(10):2368-74. PubMed ID: 8625313 [TBL] [Abstract][Full Text] [Related]
12. Cytolytic T-cell clones define HLA-A2-restricted human cutaneous melanoma peptide epitopes: correlation with T-cell receptor usage. Maeurer MJ; Hurd S; Martin DM; Storkus WJ; Lotze MT Cancer J Sci Am; 1995; 1(2):162-70. PubMed ID: 9166469 [TBL] [Abstract][Full Text] [Related]
13. Biased T cell receptor usage by Ld-restricted, tum- peptide-specific cytotoxic T lymphocyte clones. Solheim JC; Alexander-Miller MA; Martinko JM; Connolly JM J Immunol; 1993 Feb; 150(3):800-11. PubMed ID: 8380825 [TBL] [Abstract][Full Text] [Related]
14. Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma. Zeuthen J; Birck A; Straten PT Arch Immunol Ther Exp (Warsz); 1995; 43(2):123-33. PubMed ID: 8744727 [TBL] [Abstract][Full Text] [Related]
15. In vivo accumulation of the same anti-melanoma T cell clone in two different metastatic sites. Hishii M; Andrews D; Boyle LA; Wong JT; Pandolfi F; van den Elsen PJ; Kurnick JT Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1378-83. PubMed ID: 9037061 [TBL] [Abstract][Full Text] [Related]
16. Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas. Thor Straten P; Schøller J; Hou-Jensen K; Zeuthen J Int J Cancer; 1994 Jan; 56(1):78-86. PubMed ID: 8262682 [TBL] [Abstract][Full Text] [Related]
17. Shared amino acid sequences in the ND beta N and N alpha regions of the T cell receptors of tumor-infiltrating lymphocytes within malignant glioma. Ebato M; Nitta T; Yagita H; Sato K; Okumura K Eur J Immunol; 1994 Dec; 24(12):2987-92. PubMed ID: 7805726 [TBL] [Abstract][Full Text] [Related]
18. Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences. Santamaria P; Utsugi T; Park BJ; Averill N; Kawazu S; Yoon JW J Immunol; 1995 Mar; 154(5):2494-503. PubMed ID: 7868915 [TBL] [Abstract][Full Text] [Related]
19. Limited T cell antigen receptor repertoire in tumor-infiltrating lymphocyte and inhibition of experimental lung metastasis of murine melanoma by anti-TCR antibody. Wang R; Taniguchi M J Immunol; 1995 Feb; 154(4):1797-803. PubMed ID: 7836764 [TBL] [Abstract][Full Text] [Related]
20. T-cell receptor repertoire of lymphocytes infiltrating cutaneous melanoma is predominated by V alpha specificities present in T-cells of normal human skin. Strohal R; Paucz L; Pehamberger H; Stingl G Cancer Res; 1994 Sep; 54(17):4734-9. PubMed ID: 8062272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]